Australia TGA ARTG recordMultiple clinical chemistry constituent IVDs
Australia TGA ARTG Registered Device · Biomerieux Australia Pty Ltd · Biomerieux SA · Class IIa · Started February 19, 2021
Good Name: Biomerieux Australia Pty Ltd - Multiple clinical chemistry constituent IVDs
- Risk Class
- Class IIa
- Product Type
- IVD
- ARTG Category
- IVD
- Start Date
- February 19, 2021
- Effective Date
- February 19, 2021
- Name
- Biomerieux SA
- Country
- France
- Address
- 376 Chemin de l'Orme, Marcy, L Etoile, 69280
IVDs intended to be used for the qualitative and/or quantitative determination of multiple analytes (chemical, biological, and/or immunological) from more than one clinical chemistry specialty, in a clinical specimen.
Access comprehensive regulatory information for Multiple clinical chemistry constituent IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Biomerieux Australia Pty Ltd, manufactured by Biomerieux SA in France. The device registration started on February 19, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.